How should a patient with a benign endometrial adenomyoma and a cervical necrotic lesion showing acute‑on‑chronic inflammation and negative pancytokeratin be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Benign Endometrial Adenomyoma with Cervical Necrotic Lesion

The benign endometrial adenomyoma requires no specific treatment beyond routine surveillance, but the cervical necrotic lesion with negative pancytokeratin demands urgent further investigation to exclude malignancy, particularly adenoma malignum or other cervical adenocarcinoma, despite the negative epithelial marker.

Immediate Priority: Cervical Lesion Evaluation

The cervical loop excision showing necrotic tissue with acute-on-chronic inflammation and negative pancytokeratin is highly concerning. While negative cytokeratin typically suggests absence of epithelial tissue, this finding in the context of necrosis can represent:

  • Extensive necrosis obscuring epithelial markers
  • Non-epithelial malignancy (though less likely in cervix)
  • Severe inflammatory process with tissue destruction

Required Next Steps for Cervical Lesion:

  1. Repeat cervical biopsy from viable tissue margins (not necrotic center) with deeper sampling
  2. Cold knife conization (CKC) if adequate tissue cannot be obtained otherwise 1
  3. Pelvic MRI to assess extent of cervical involvement and exclude parametrial disease 2
  4. Expert gynaecopathologist review of all cervical specimens 2

The negative pancytokeratin does not exclude malignancy—it may simply reflect sampling of necrotic tissue where antigens are degraded. Adenoma malignum (minimal deviation adenocarcinoma) can be particularly challenging to diagnose and may show bland-appearing glands that are easily missed 3.

Management of Endometrial Adenomyoma

The endometrial adenomyoma findings are reassuring:

  • Bland spindle cells in fascicles
  • Ectopic endometrial glands with columnar epithelium
  • No atypia, necrosis, or significant mitotic activity

This benign lesion requires no specific intervention 4, 5. However:

Surveillance Recommendations:

  • Clinical examination every 6 months for first year, then annually 6
  • Transvaginal ultrasound annually to monitor for changes 7
  • Endometrial sampling only if abnormal bleeding develops 8

Do not perform hysterectomy for the adenomyoma alone unless the patient has completed childbearing and desires definitive management for symptoms 5.

Critical Diagnostic Algorithm

Step 1: Cervical Pathology Resolution (URGENT)

  • Obtain adequate non-necrotic tissue via repeat biopsy or CKC
  • Request additional IHC panel: p16, CEA, vimentin, ER/PR
  • If CKC shows invasive cancer → stage and treat per cervical cancer guidelines 1
  • If CKC shows AIS or microinvasion → consider radical hysterectomy vs fertility-sparing options 1

Step 2: If Cervical Workup Benign

  • Continue surveillance for adenomyoma as outlined above
  • Address any symptoms (bleeding, pain) with medical management
  • Consider hysterectomy only if:
    • Childbearing complete AND
    • Symptomatic disease refractory to medical therapy

Step 3: If Cervical Workup Shows Malignancy

  • Stage appropriately with imaging (CT chest/abdomen/pelvis or PET-CT) 8
  • Multidisciplinary tumor board discussion
  • Treatment per stage and histology (likely requires hysterectomy, which would address both lesions)

Key Pitfalls to Avoid

  1. Do not assume negative pancytokeratin excludes malignancy in necrotic tissue—this is the most critical error. Necrosis destroys antigenic epitopes.

  2. Do not treat the benign adenomyoma with hysterectomy without addressing the cervical lesion first—you need definitive diagnosis of the cervical pathology to plan appropriate surgery.

  3. Do not perform simple hysterectomy if cervical malignancy is confirmed—this would be inadequate treatment 9.

  4. Do not delay cervical workup—the combination of necrosis and inflammation suggests an aggressive process that requires urgent clarification.

Patient Counseling Points

  • The endometrial finding is benign and not a cancer risk
  • The cervical finding is indeterminate and requires additional tissue sampling
  • Necrosis in cervical tissue is abnormal and must be fully investigated
  • If cervical cancer is found, it will require more extensive surgery than initially anticipated
  • Fertility preservation may still be possible depending on final cervical diagnosis, but only if early-stage disease is confirmed

The management priority is resolving the cervical pathology diagnosis through adequate tissue sampling, not treating the benign endometrial adenomyoma 1, 3.

References

Guideline

cervical cancer screening.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Research

Adenomyomas of the uterine cervix of of endocervical type: a report of ten cases of a benign cervical tumor that may be confused with adenoma malignum [corrected].

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 1996

Research

Atypical polypoid adenomyomas of the endometrium.

The American journal of surgical pathology, 1981

Research

Uterine adenomyoma: a clinicopathologic review of 26 cases and a review of the literature.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2006

Guideline

carcinoma of the cervix.

British Journal of Cancer, 2001

Guideline

acr appropriateness criteria® abnormal uterine bleeding.

Journal of the American College of Radiology, 2020

Guideline

current recommendations and recent progress in endometrial cancer.

Ca-A Cancer Journal for Clinicians, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.